Fondazione Istituto Nazionale di Genetica Molecolare Ingm

Fondazione Istituto Nazionale di Genetica Molecolare Ingm is a research organisation in Milano, Italy that has taken part in 9 EU-funded projects since 2011, receiving €9.6M in EU funding and leading 2 as coordinator.

EU funding received€9.6M
EU projects9
As coordinator2
Running now3
First EU project2011
Latest project2025
CountryItaly
EU registration (PIC)998645168
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fondazione Istituto Nazionale di Genetica Molecolare Ingm's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€5.8M · 4 projects
  • Horizon 2020€2.7M · 3 projects
  • Horizon Europe€1.1M · 2 projects

Projects

9 EU-funded projects, newest first. Fondazione Istituto Nazionale di Genetica Molecolare Ingm led 2 of them as coordinator. Each links to the official record.

  • InFlaMePartner

    Counter-acting the pandemic potential of flaviviruses: addressing virus-host interactions and defense strategies to design new therapeutics against WNV and DENV

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €1.1Mtheir share
  • BEHIND-MSAssociated partner

    The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • ENGRABCoordinator

    Antibody engineering by natural selection and by design

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €2.5Mtheir share
  • PANDORAPartner

    Pandemics Outbreaks Rationalized: towards a universal therapy to eliminate intracellular pathogens and drug resistance

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €63ktheir share
  • HD-DittoGraphPartner

    HD-DittoGraph: a digital human Embryonic Stem Cell platform for Huntington's repeats

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €173ktheir share
  • nuc-inositideCoordinator

    Investigating the topography of nuclear phosphoinositide signalling in relation to chromatin and the genome

    FP7 (2007 to 2013) · 2015–2017 · Project on CORDIS ↗

    €249ktheir share
  • TRANSLATEPartner

    Noncoding and Translational Modulation of Gene Expression and Epigenetic Changes

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €1.7Mtheir share
  • FIGHT-CANCERPartner

    Long non-coding RNAs of tumor infiltrating lymphocytes as novel anti-cancer therapeutic targets

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €1.3Mtheir share
  • I-MIRNOMEPartner

    Lymphocyte microRNAs in health and disease: Understanding lymphocyte functions through the identification of microRNA target genes and exploiting serum microRNA signatures to monitor immune responses

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €2.5Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • cell biology
  • drug discovery
  • drug resistance
  • enzymes
  • genomes
  • homeostasis
  • immunology
  • immunotherapy
  • infectious diseases
  • pandemics
  • planetary geology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime